Is platelet activating factor (PAF) an important mediator in bronchial asthma?
The development of selective PAF receptor antagonists may provide a novel approach to the treatment of human bronchial asthma. In preclinical animal models of human asthma, PAF receptor antagonists have been found to be efficacious in blocking antigen-induced changes in lung function. However, the m...
| Published in: | Mediators of Inflammation |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1992-01-01
|
| Online Access: | http://dx.doi.org/10.1155/S0962935192000541 |